Zierhut S, Reichle A
Intensivmed Notfallmed. 2020; 44(5):286-302.
PMID: 32287640
PMC: 7101893.
DOI: 10.1007/s00390-007-0783-9.
Ray-Coquard I, Ghesquiere H, Bachelot T, Borg C, Biron P, Sebban C
Br J Cancer. 2001; 85(6):816-22.
PMID: 11556830
PMC: 2375083.
DOI: 10.1054/bjoc.2001.2011.
Matsumoto T, Takahashi K, Tanaka M, Kumazawa J
Int Urol Nephrol. 1999; 31(1):7-14.
PMID: 10408296
DOI: 10.1023/a:1007107403610.
El-Yazigi A, Ellis M, Ernst P, Spence D, Hussain R, Baillie F
Antimicrob Agents Chemother. 1997; 41(5):914-7.
PMID: 9145843
PMC: 163824.
DOI: 10.1128/AAC.41.5.914.
Rossi C, Klastersky J
Support Care Cancer. 1996; 4(3):207-12.
PMID: 8739654
DOI: 10.1007/BF01682342.
Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
Van der Auwera P, Duchateau V, Lambert C, Husson M, Kinzig M, Sorgel F
Antimicrob Agents Chemother. 1993; 37(9):1860-8.
PMID: 8239597
PMC: 188083.
DOI: 10.1128/AAC.37.9.1860.
Economic study of neutropenia induced by myelotoxic chemotherapy.
Montero M, Valdivia M, Carvajal E, Montano A, Buenestado C, Lluch A
Pharm World Sci. 1994; 16(4):187-92.
PMID: 7951132
DOI: 10.1007/BF01872867.
Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin.
Onyeji C, Nightingale C, Marangos M
Infection. 1994; 22(5):338-42.
PMID: 7843812
DOI: 10.1007/BF01715542.
Intensive care and oncology.
Sculier J
Support Care Cancer. 1995; 3(2):93-105.
PMID: 7773586
DOI: 10.1007/BF00365848.
Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies.
Serra P, Santini C, Venditti M, Mandelli F, Martino P
Infection. 1985; 13 Suppl 1:S115-22.
PMID: 4055041
DOI: 10.1007/BF01644231.
Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
Van der Auwera P, Klastersky J
Antimicrob Agents Chemother. 1986; 30(6):892-5.
PMID: 3813515
PMC: 180614.
DOI: 10.1128/AAC.30.6.892.
BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers.
Van der Auwera P, Lieppe S, Klastersky J
Antimicrob Agents Chemother. 1986; 29(5):757-9.
PMID: 3755314
PMC: 284149.
DOI: 10.1128/AAC.29.5.757.
Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.
Roosendaal R, Michel M
Antimicrob Agents Chemother. 1986; 30(3):403-8.
PMID: 3535664
PMC: 180569.
DOI: 10.1128/AAC.30.3.403.
Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
Roosendaal R, Michel M
Pharm Weekbl Sci. 1987; 9 Suppl:S33-40.
PMID: 3325928
DOI: 10.1007/BF02075257.
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
Roosendaal R, Michel M
Antimicrob Agents Chemother. 1987; 31(11):1809-15.
PMID: 3324962
PMC: 175044.
DOI: 10.1128/AAC.31.11.1809.
Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.
Van der Auwera P, Klastersky J
Antimicrob Agents Chemother. 1987; 31(7):1061-8.
PMID: 3116918
PMC: 174872.
DOI: 10.1128/AAC.31.7.1061.
Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.
Van der Auwera P, Klastersky J, Lagast H, Husson M
Antimicrob Agents Chemother. 1986; 30(1):122-6.
PMID: 3092729
PMC: 176448.
DOI: 10.1128/AAC.30.1.122.
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.
Van der Auwera P, Klastersky J, Lieppe S, Husson M, Lauzon D, Lopez A
Antimicrob Agents Chemother. 1986; 29(2):230-4.
PMID: 3087276
PMC: 176382.
DOI: 10.1128/AAC.29.2.230.
Bactericidal activity and killing rate of serum in volunteers receiving teicoplanin alone or in combination with oral or intravenous rifampin.
Van der Auwera P, Klastersky J
Antimicrob Agents Chemother. 1987; 31(7):1002-5.
PMID: 2959197
PMC: 174860.
DOI: 10.1128/AAC.31.7.1002.
Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.
Van der Auwera P
Antimicrob Agents Chemother. 1989; 33(10):1783-90.
PMID: 2556079
PMC: 172755.
DOI: 10.1128/AAC.33.10.1783.